The FSE Group
UK fund manager appointed by the British Business Bank to run regional investment funds.
Last refreshed: 4 July 2026 · Appears in 1 active topic
Timeline for The FSE Group
Exeter spinout raises GBP3m for epilepsy
UK Startups and InnovationCo-invested in Mykor's £4m round
UK Startups and Innovation: Mykor's £4m grows panels from mushroomsWhat is The FSE Group?
What deals has The FSE Group backed in 2026?
Which British Business Bank funds does The FSE Group manage?
Background
The FSE Group co-led Exeter University spinout Neuronostics' £3m round for BioEP, a digital epilepsy biomarker, alongside Empirical Ventures and a blended £400k Innovate UK Investor Partnerships grant, announced 30 June 2026. A month earlier it co-invested in Bristol mycelium-materials firm Mykor's £4m round alongside the Clean Growth Fund and Green Angel Ventures.
Founded in 2002, The FSE Group provides market-gap funding to high-growth UK businesses and is an appointed fund manager for several British Business Bank regional programmes, including the South West Investment Fund, the Cornwall & Isles of Scilly Investment Fund and the Investment Fund for Scotland, writing loans and equity of £100,000 to £5m.
Both its 2026 deals sit in the sub-£5m early-stage tier that the sector's national tracker shows contracting sharply, and both blend its own regional-fund capital with a specialist co-lead and a government grant, the pattern the British Business Bank is now relying on to keep the smallest deeptech and life-sciences spinouts funded as retail angel capital thins.
